This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Capitalbio Corporation, Tsinghua University, Sichuan University. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2023-2026
Title: Fei Wen: Innovator in Nucleic Acid Extraction Technologies
Introduction
Fei Wen is a prominent inventor based in Beijing, China. He has made significant contributions to the field of nucleic acid extraction, with a focus on developing efficient and user-friendly methods. His innovative approaches have led to the creation of two notable patents that enhance the speed and safety of nucleic acid extraction processes.
Latest Patents
Fei Wen's latest patents include a nucleic acid extraction composition, reagent, and kit that are free of volatile organic solvents. This innovation prevents the harmful effects of such solvents on users and significantly improves the timeliness of nucleic acid extraction, allowing for results in as little as 10 minutes. The extracted nucleic acids can be utilized in various biological reactions, including PCR, NASBA, LAMP, and RPA. Additionally, his second patent involves a sample extraction chip and a biological reaction device, which features a sophisticated design for efficient sample processing.
Career Highlights
Throughout his career, Fei Wen has worked with notable organizations such as Capitalbio Corporation and Sichuan University. His experience in these institutions has allowed him to refine his skills and contribute to advancements in biotechnology.
Collaborations
Fei Wen has collaborated with esteemed colleagues, including Xiang Chen and Lei Wang. Their combined expertise has fostered a productive environment for innovation and research.
Conclusion
Fei Wen's contributions to nucleic acid extraction technologies exemplify his commitment to advancing scientific research. His patents not only improve efficiency but also enhance safety in laboratory settings.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile